Literature DB >> 26673988

Oral steroid contraception.

Laura A Sech1, Daniel R Mishell1.   

Abstract

Oral steroid contraception is a popular method of family planning worldwide. Over the past several decades, this method of contraception has changed significantly by decreasing the estrogen dose, changing the progestin component, and reducing the hormone free interval. Despite the popularity of oral steroid contraception, there has been much criticism regarding the associated risks of venous thromboembolism and stroke. Despite these established, yet uncommon risks, oral steroid contraception has many important health benefits. This review highlights the available formulations of oral contraceptives along with their evidence-based associated risks and benefits. Highlights regarding future directions for development of novel oral contraceptives are also addressed.

Entities:  

Keywords:  birth control; cancer risk; novel contraception; progestins; steroid contraception; venous thromboembolism

Mesh:

Substances:

Year:  2015        PMID: 26673988     DOI: 10.2217/whe.15.82

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  3 in total

Review 1.  Hormone therapy and melanoma in women.

Authors:  Madison S Hill; Alexander M Cartron; Mary Burgoyne; Marcia S Driscoll
Journal:  Int J Womens Dermatol       Date:  2021-06-25

2.  Knowledge and Perception Regarding the Development and Acceptability of Male Contraceptives Among Pharmacists: A Mixed Sequential Method.

Authors:  Muna Barakat; Samar Thiab; Sara Thiab; Raja'a A Al-Qudah; Amal Akour
Journal:  Am J Mens Health       Date:  2022 Jan-Feb

3.  Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.

Authors:  Sebastian Simu; Iasmina Marcovici; Amadeus Dobrescu; Daniel Malita; Cristina Adriana Dehelean; Dorina Coricovac; Flavius Olaru; George Andrei Draghici; Dan Navolan
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.